HOME >> BIOLOGY >> NEWS
New drug discovery spin-off from CSIRO

CSIRO Entomology today announced the establishment of a company dedicated to producing a wide range of therapeutic drugs from a virtually untapped source - insects.

"Entocosm Pty Ltd has been established to develop the leading global position on developing drugs from insects," CSIRO's Chief Executive, Dr Geoff Garrett, said.

There are around 250,000 plant species on earth but there are more than four million insect species. Microbial diversity is also huge, although 99% of bacteria cannot be cultured in the laboratory.

"The plant and microbial worlds have long been targets for discovery of therapeutic drugs, but insects have been left virtually untouched," Dr Garrett said.

"With four million species to be looked at, there is great potential for discovery of hugely important therapeutic drugs in the future."

Insects utilise an unparalleled array of biologically active substances. These include molecules that kill cancer cells, proteins that prevent blood from clotting, enzymes that degrade pesticides, proteins that glow in the dark, anti-microbial peptides and toxins. Australia, with its mega-diverse biota and advanced scientific infrastructure, offers unique potential for discovery.

Entocosm's Chief Scientific Officer, Dr Stephen Trowell (a CSIRO scientist for the past 13 years), will work with: Emeritus Professor, Rod Rickards, from the Australian National University; and, Clinical Associate Professor at The Canberra Hospital, Peter Collignon, to identify novel drug candidates from insects.

Due to the urgent demand for new agents to treat drug-resistant pathogens, the team will initially focus on discovering new antibiotics.

"Dr Trowell's team has already uncovered a wealth of novel antibiotic potential from insects and the formation of Entocosm Pty Ltd enables the company to screen CSIRO's unique library of insect extracts and develop the novel drug leads through the drug discovery pipeline,"
'"/>

Contact: Rosie Schmedding
rosie.schmedding@csiro.au
61-2-6-276-6520
CSIRO Australia
22-Jul-2002


Page: 1 2

Related biology news :

1. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
2. New OHSU lab will speed drug discovery process
3. New discovery may help transplants survive
4. Genetic discovery could dramatically reduce need for liver transplants in children
5. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
6. Major scientific discovery in cancer research to be honored
7. New discovery could provide tool to detect whether a cancer will develop and spread
8. UNC research accelerates discovery of novel gene function
9. Tulane opens doors to discovery
10. U. Iowa muscular dystrophy discovery may lead to new treatment approaches
11. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment ... in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred ...
(Date:6/28/2020)... Fla. (PRWEB) , ... June 25, 2020 , ... In ... focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local listings ... Samples are collected at medical offices and are shipped to labs throughout the country. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
Breaking Biology Technology:
Cached News: